Evaluation of Dry Eye Treatment with Sodium Hyaluronate- and Dexpanthenol-Containing Eye Drops on Ocular Surface Improvement after Cataract Surgery.
Maximilian K KöppeMustafa K HallakAnnette L StengeleIsabella D BaurGerd Uwe AuffarthPublished in: Diagnostics (Basel, Switzerland) (2024)
Controlled standardized dry eye treatment (with HC) improved tear film stability, ocular surface defects, and subjective symptoms of dry eye disease in patients 5 weeks after undergoing cataract surgery. Both the patient and physician assessments indicated high efficacy, tolerability, and a reliable safety profile, as indicated by the low number of at least possibly related adverse events (AE), suggesting its beneficial role in the postoperative management of the ocular surface (OS) in patients with dry eye symptoms prior to and after cataract surgery.
Keyphrases
- cataract surgery
- end stage renal disease
- emergency department
- primary care
- ejection fraction
- newly diagnosed
- sleep quality
- patients undergoing
- clinical trial
- prognostic factors
- peritoneal dialysis
- open label
- combination therapy
- case report
- physical activity
- drug induced
- room temperature
- preterm birth
- placebo controlled